SGM
Skye Global Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.4M | Buy |
146,500
+51,500
| +54% | +$20.9M | 1.03% | 17 |
|
|
2025
Q1 | $47.3M | Sell |
95,000
-11,500
| -11% | -$5.72M | 1.26% | 17 |
|
|
2024
Q4 | $55.4M | Buy |
106,500
+46,500
| +78% | +$24.2M | 1.16% | 16 |
|
|
2024
Q3 | $37.1M | Buy |
60,000
+5,000
| +9% | +$3.09M | 0.9% | 17 |
|
|
2024
Q2 | $30.4M | Sell |
55,000
-10,800
| -16% | -$5.97M | 0.69% | 18 |
|
|
2024
Q1 | $38.2M | Sell |
65,800
-42,200
| -39% | -$24.5M | 0.91% | 15 |
|
|
2023
Q4 | $57.3M | Buy |
108,000
+2,000
| +2% | +$1.06M | 1.64% | 9 |
|
|
2023
Q3 | $53.7M | Buy |
106,000
+22,000
| +26% | +$11.1M | 1.56% | 11 |
|
|
2023
Q2 | $43.8M | Buy |
84,000
+62,000
| +282% | +$32.3M | 1.21% | 11 |
|
|
2023
Q1 | $12.7M | Buy |
+22,000
| New | +$12.7M | 0.41% | 17 |
|
|
2022
Q2 | – | Sell |
-7,000
| Closed | -$4.14M | – | 31 |
|
|
2022
Q1 | $4.14M | Sell |
7,000
-6,500
| -48% | -$3.84M | 0.07% | 21 |
|
|
2021
Q4 | $9.01M | Sell |
13,500
-6,800
| -33% | -$4.54M | 0.15% | 32 |
|
|
2021
Q3 | $11.6M | Buy |
20,300
+7,300
| +56% | +$4.17M | 0.19% | 31 |
|
|
2021
Q2 | $6.56M | Buy |
13,000
+9,600
| +282% | +$4.84M | 0.12% | 33 |
|
|
2021
Q1 | $1.55M | Sell |
3,400
-3,400
| -50% | -$1.55M | 0.03% | 47 |
|
|
2020
Q4 | $3.17M | Buy |
6,800
+4,200
| +162% | +$1.96M | 0.07% | 35 |
|
|
2020
Q3 | $1.15M | Buy |
+2,600
| New | +$1.15M | 0.03% | 52 |
|
|
2019
Q2 | – | Sell |
-2,900
| Closed | -$794K | – | 46 |
|
|
2019
Q1 | $794K | Buy |
+2,900
| New | +$794K | 0.1% | 33 |
|